Correlation Between Mitake Information and GeneFerm Biotechnology

Can any of the company-specific risk be diversified away by investing in both Mitake Information and GeneFerm Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mitake Information and GeneFerm Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mitake Information and GeneFerm Biotechnology Co, you can compare the effects of market volatilities on Mitake Information and GeneFerm Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mitake Information with a short position of GeneFerm Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mitake Information and GeneFerm Biotechnology.

Diversification Opportunities for Mitake Information and GeneFerm Biotechnology

0.28

Correlation Coefficient

Mitake Information  GeneFerm Biotechnology

Modest diversification

The 3 months correlation between Mitake and GeneFerm is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Mitake Information and GeneFerm Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneFerm Biotechnology and Mitake Information is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mitake Information are associated (or correlated) with GeneFerm Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneFerm Biotechnology has no effect on the direction of Mitake Information i.e., Mitake Information and GeneFerm Biotechnology go up and down completely randomly.

Pair Corralation between Mitake Information and GeneFerm Biotechnology

Assuming the 90 days trading horizon Mitake Information is expected to generate 0.38 times more return on investment than GeneFerm Biotechnology. However, Mitake Information is 2.62 times less risky than GeneFerm Biotechnology. It trades about 0.04 of its potential returns per unit of risk. GeneFerm Biotechnology Co is currently generating about -0.03 per unit of risk. If you would invest  5,545  in Mitake Information on October 25, 2024 and sell it today you would earn a total of  1,025  from holding Mitake Information or generate 18.49% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	99.8%
Values	Daily Returns

Mitake Information  vs.  GeneFerm Biotechnology Co

Mitake Information

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Mitake Information are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Mitake Information is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

GeneFerm Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeneFerm Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Mitake Information and GeneFerm Biotechnology

The main advantage of trading using opposite Mitake Information and GeneFerm Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mitake Information position performs unexpectedly, GeneFerm Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneFerm Biotechnology will offset losses from the drop in GeneFerm Biotechnology's long position.

The idea behind Mitake Information and GeneFerm Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..